Spandana Sphoorty Financial Ltd (542759)- New customers added in Q1FY24 increased by 144% YoY

Spandana Sphoorty Financial Ltd (542759) closes   at ₹799.10  with  a   Fall   of   -2.70%   on    30-Aug-2023  with formation of  a    Red  candle  on Daily  Price Chart.

About the Company : Spandana Sphoorty Financial is primarily engaged in the business of micro finance providing small value unsecured loans to low-income customers in semi-urban and rural areas.

Sector Update :  Positive

Trendlyne Checklist Score : 34.80% pass

Financials : Spandana Sphoorty Financial Ltd has posted Net Interest Income (NII)  of ₹819.60 Cr & Net Profit of   ₹12.40 Cr in FY2023 and expected to post NII   of ₹1270.30 Cr  & Net Profit of ₹515.40  Cr in FY2024, NII   of ₹1680.00 Cr  & Net Profit of ₹724.20 in FY2025 .

Valuations  : The Company is now Trading at X1.70  of its  valuations of  FY2023 (Last 4 Quarters ) earnings with ~70% Premium  ;  at X0.79 of its FY2024 earnings with ~21%  Discount ; at X0.57 of its FY2025 earnings with ~43%  Discount .

EPS will improve from 1.70  in FY2023 to 102 by FY2023 and RoAE from 0.2% to 5.1% ; Book Value Per Share will increase from ₹437 to ₹594 during the same period.

Early Trend : Increasing Loan Officer with opening of new office .

MF/FII : FII- 21.25; MF-0.64%

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.60   which  will improve further..The  Equity Value Per Share ( Enterprise Value Method ) is  ₹659.  If We factor its FY2025 earnings/valuations, relative to current valuations,  its Price arrives at ₹2404.00

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |Refinitiv |Trendlyne |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

Ami Organics Ltd (543349)- Electrolyte business will add value

Ami Organics Ltd (543349) closes   at ₹1317.60  with  a   Fall  of   -1.30%   on    29-Aug-2023  with formation of  a    Red  candle  on Daily  Price Chart.

About the Company : Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.

Sector Update :  Positive

Trendlyne Checklist Score : 50.00 % pass

Financials : Ami Organics Ltd has posted Net Sales / Revenue   of ₹616.70 Cr & Net Profit of   ₹83.30 Cr in FY2023 and expected to post Net Sales / Revenue   of ₹753.40 Cr  & Net Profit of ₹97.80 Cr in FY2024, Net Sales / Revenue   of ₹940.20 Cr  & Net Profit of ₹146.10 in FY2025 and Net Sales / Revenue   of ₹1121.00 Cr  & Net Profit of ₹180.90 Cr in FY2026.

Valuations  : The Company is now Trading at X5  of its  valuations of  FY2023 (Last 4 Quarters ) earnings with ~400% Premium  ;  at X3.53 of its FY2024 earnings with ~253%  Premium ; at X2.36 of its FY2025 earnings with ~136%  Premium and at X1.91 of its FY2026 earnings with ~91%  Premium.

Company will increase  its Reserve & Surplus  of ₹557.50 Cr in FY 2023 to ₹799.80 Cr by FY 2025 along with Improvement in ROD from 14.90%  in FY 2023 to 20.60% by FY2025 and EPS from 23 to 37 during the same period.

Early Trend : Company is going through large Capex plan

MF/FII : Mutual Fund – 4.49%. FII – 6.73% ( MORGAN STANLEY ASIA SINGAPORE PTE NON ODI has purchased 621,898 shares on 29.08.2023)

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.20  which  makes it a concern due to large capedx plan during 2023-2025.The  Equity Value Per Share ( Enterprise Value Method ) is  ₹1301.00 . It’s a Growth Stock as per our calculations , Growth Candidate ( If >1 ) is 1.02 . If We factor its FY2026 earnings/valuations, relative to current valuations,  its Price arrives at ₹3450.00

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |Refinitiv |Trendlyne |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

India's Chandrayaan Success and Investment Theme

Today(23.08.2023)  is a historic day for India. The country's Chandrayaan-3 has  landed on the lunar south pole. Now lets explore the Equity Space, which are going to be beneficial -

1. Larsen & Toubro Ltd (500510)

2. Avantel Ltd (532406)

3. Mishra Dhatu Nigam Ltd(541195)

4. Data Patterns (India) Ltd (543428)

5. Walchandnagar Industries Ltd ( 507410)

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |Refinitiv |Trendlyne |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

Chamanlal Setia Exports Ltd (530307)- Increased Basmati Rice Price Realisation in 2023

Chamanlal Setia Exports Ltd (530307) closes   at ₹183.50  with  a   Gain  of   +1.00%   on    16-Aug-2023  with formation of  a    bullish Green  candle  on Daily  Price Chart.

About the Company : . Chaman Lal Setia Exports Limited (CLSE) was incorporated in Amritsar, Punjab in 1994 by Mr. Chaman Lal Setia and his sons. [1] It’s one of the oldest Rice Millers cum Exporters of Basmati rice of all varieties from India. The company is engaged in the business of milling and processing basmati rice. The company has been involved in export operations since 1982 and was recognized as an export house by the Ministry of Commerce in 1989, at present the company is a ‘Star Export House’.

Sector Update :  Positive

Trendlyne Checklist Score : 65.2% pass

Financials : Chaman Lal Setia Exports Limited (CLSE) has posted Net Sales / Revenue   of ₹1387.30 Cr & Net Profit of   ₹117.70 Cr in FY2023 and expected to post Net Sales / Revenue   of ₹1432.70 Cr  & Net Profit of ₹135.80 Cr in FY2024, Net Sales / Revenue   of ₹1551.70 Cr  & Net Profit of ₹162.40 in FY2025 and Net Sales / Revenue   of ₹1671.00 Cr  & Net Profit of ₹172.50 Cr in FY20.26.

Valuations  : The Company is now Trading at X0.70  of its  valuations of  FY2023 (Last 4 Quarters ) earnings with ~30% Discount  ;  at X0.50 of its FY2024 earnings with ~50%  Discount ; at X0.42 of its FY2025 earnings with ~68%  Discount and at X0.40 of its FY2026 earnings with ~60%  Discount.

Company will reduce its total debt of ₹120.50 Cr in FY 2023 to ₹118.50 Cr by FY 2026 along with Improvement in Operating Profit Maring(OPM) from 11.50% (FY2023) to 14.40% ( FY2026); Net Profit Magin from 8.5% to 10.30%; Net Worth from ₹608.50 Cr to ₹1063.70 Cr.

Price to Book Value Per Share  will  improve from X1.60 in FY2023 to X0.9 in FY2026  and EPS from 22.74 to 33.35 during the same period.

Early Trend : Government banned exports of non-basmati white rice in order to boost domestic supply and keep retail prices under check during the upcoming festive season.

MF/FII : FII/FPI have increased holdings from 1.17% to 1.85% in Jun 2023 qtr.

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  1.40  which  makes it attrative..The  Equity Value Per Share ( Enterprise Value Method ) is  ₹174.90  If We factor its FY2026 earnings/valuations, relative to current valuations,  its Price arrives at ₹464.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |Refinitiv |Trendlyne |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

Highest YoY Net Profit Growth - June 2023

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |Refinitiv |Trendlyne |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D

Laurus Labs Ltd (540222)- Growing in Contract Development and Manufacturing Organisation (CDMO) space

Laurus Labs Ltd  (540222)  closes   at ₹400.30  with  a   Gain  of   +2..10%   on    07-Aug-2023  with formation of  a    bullish Green  candle  on Daily  Price Chart.

About the Company :  Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership
position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing.
Laurus employs 6500+ people, including around 1050+ scientists at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc. 

Sector Update :  Positive

Refinitiv  Average Score : 2/ 10

Financials : Laurus Labs Ltd   has posted Net Sales / Revenue   of ₹6040.60 Cr & Net Profit of   ₹790.10 Cr in FY2023 and expected to post Net Sales / Revenue   of ₹5885.30 Cr  & Net Profit of ₹567.30 Cr in FY2024, Net Sales / Revenue   of ₹6756.60 Cr  & Net Profit of ₹1838.70 in FY2025 and Net Sales / Revenue   of ₹7666.60 Cr  & Net Profit of ₹1104.90 Cr in FY20.26.

Valuations  : The Company is now Trading at X2.90  of its  valuations of  FY2023 (Last 4 Quarters ) earnings with ~190% premium  ;  at X2.73 of its FY2024 earnings with ~173%  Premium ; at X1.85 of its FY2025 earnings with ~85%  Premium and at X1.40 of its FY2026 earnings with ~40%  Premium

Company will reduce its total debt of ₹1923.50 Cr in FY 2023 to ₹1736.60 by FY 2026 along with Improvement in Net Margin from 13.10 (FY2023) to 14.40% ( FY2026).

Book Value Per Share  will  improve from ₹75.00 in FY2023 to ₹107.00 in FY2026  and EPS from 14.60 to 20.60 .

Early Trend : Huge Capex in FY2024 for CDMO Business.

MF/FII : 2.70% MF Holding & 5.40% FII Holding

Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.4  which  will increase  in FY2024-25.The  Equity Value Per Share ( Enterprise Value Method ) is  ₹400.30  If We factor its FY2026 earnings/valuations, relative to current valuations,  its Price arrives at ₹826.00

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control |Refinitiv |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D